SEQENS Competitors and Similar CompaniesClear all

SEQENS's competitors and similar companies include Sartorius Stedim Biotech and Dottikon.
SEQENS
SEQENS
SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients.
Sartorius Stedim Biotech
Sartorius Stedim Biotech
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
Dottikon
Dottikon
Dottikon ES Holding is a company that manufactures active pharmaceutical ingredients, intermediates, and performance chemicals.
Founding Date
Founding Date
2003
Founding Date
2007
Founding Date
1913
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Écully, FR HQ
Saint Jean Sur Richelieu, CA
Taizhou Shi, CN
Zhenjiang, CN
Turku, FI
Bourgoin Jallieu, FR
see more
Locations
Aubagne, FR HQ
Jaipur, IN
Bohemia, US
Locations
Dottikon, CH HQ
Employees
Employees
3,300
Employees
9,961
Employees
770

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€3b (FY, 2025)
Revenue (est.)
CHF385.2m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
€1.3b (FY, 2025)
Cost of goods
CHF125.7m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
€1.7b (FY, 2025)
Gross profit
CHF261.3m (FY, 2025)
Net income
Net income
N/A
Net income
€265.9m (FY, 2025)
Net income
CHF105.6m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Sartorius Stedim Biotech
HQ
Aubagne, FR
Employees
9,961

Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.

View company
Dottikon
HQ
Dottikon, CH
Employees
770

Dottikon ES Holding is a company that manufactures active pharmaceutical ingredients, intermediates, and performance chemicals.

View company